Latest news with #RajanKohli
Mint
a day ago
- Business
- Mint
Bain Capital-backed CitiusTech exploring acquisitions, to evaluate IPO
Bain Capital-backed CitiusTech, a healthcare technology services company, is planning to grow through acquisitions and will evaluate an IPO this year, either in the US or India, chief executive officer (CEO) Rajan Kohli told Mint in an interview. 'It is very much in our growth path," Kohli said, referring to the company's plan to list on the exchanges. 'We will evaluate [it] this year if the markets are good," he said, adding that the company will evaluate listing in either India or the US. The firm's primary market is the US, accounting for 95% of its revenues. Its investors are Bain Capital Private Equity and EQT Private Capital Asia (previously Baring Private Equity Asia). Also read: FPI Tracker: Telecom, services, capital goods corner major chunk of inflows; IT, healthcare face heavy selling in May In 2022, Bloomberg reported, citing people in the know, that CitiusTech had filed confidentially for a US IPO. The health tech firm is planning expansions in Europe and Japan, as demand for healthcare technology services increases among medtech, healthcare, and life sciences companies. Kohli said that the firm's specialised focus on healthcare gives it an edge over large Indian IT service companies that cater to various industries. A few other Indian companies are focused solely on healthcare tech services, like IKS Health, which was listed on the exchanges in December 2024 and posted ₹2,664 crore revenue in FY25. Acquisitions drive growth The firm is looking at acquisitions this year to drive growth. 'We didn't make any acquisitions for the last two years because the valuation was not great in the market," Kohli said, adding that this year the company is targeting two acquisitions, provided it finds targets that meet its requirements. CitiusTech is exploring acquisition options which would strengthen its foray into Europe as well as enhance its abilities in the healthcare provider market. Also read: Jainik Power and Cables IPO allotment to be out soon: Here are steps to check status online and GMP The company had previously stated a target of $1 billion in revenue by FY28, which it is still aiming for, Kohli said. 'On an organic basis, we continue to grow as per plan," he said. The company is expecting mid-teens revenue growth in FY26, after high single-digit revenue growth in FY25, Kohli said. While it hasn't yet posted its FY25 results, it clocked revenue of ₹3,536 crore and a profit of ₹350 crore in FY24. GenAI tailwind Kohli sees GenAI as a significant tailwind driving growth, as companies look for cost optimisation solutions. '...today, 25% of our clients give us the opportunity to use GenAI tools. I think in one or two years, 80-100% of our clients will allow GenAI-produced code into their environment," he said. Also read: Aten Papers & Foam IPO Day 1: Check subscription status, GMP, and other details Being a healthcare-focused service provider gives CitiusTech an edge as well, according to Kohli. 'It is a huge advantage being just focused on healthcare because a lot of our clients buy us because of our specialised capabilities. All our investment, all our R&D, all our training goes into healthcare only," he said.
Forbes
26-03-2025
- Health
- Forbes
Generative AI In Healthcare: Innovation Amid Crises
Rajan Kohli, CEO of CitiusTech. Inspiring new possibilities for the health ecosystem with technology and human ingenuity. In conversations with healthcare executives and innovators across the healthcare industry, one sentiment echoes: Healthcare's challenges are as complex as its opportunities are vast. I have had leaders share stories of unrelenting pressure—from operational inefficiencies to skyrocketing patient demand—and how these are compounded by workforce shortages and the rising burden of chronic diseases. Technological innovators in the space race to develop solutions faster than regulations can adapt. Life sciences firms face spiraling R&D costs and a relentless demand for speed in drug discovery and clinical trials. But within these struggles, I believe generative AI has emerged as healthcare's most intriguing disruptor. Reports highlight generative AI's potential to cut R&D timelines, personalize patient engagement at scale and redefine clinical trial design with unprecedented speed and accuracy. It's moving beyond proof-of-concept into actionable transformation. With AI's applications in real-time transcription for electronic health records, automated claims processing and even AI-assisted diagnostics, generative AI is nudging the payer industry toward a more intelligent, agile future. In medtech, the technology is turning clinical workflows into intelligence-driven systems. Ambient listening converts clinician-patient conversations into structured data. In emergency rooms, GenAI can help prioritize cases in real time, enabling life-saving decisions. On top of this, automated billing can reduce delays, and clinical trial recruitment can align patient data with eligibility criteria. It's also revolutionizing drug discovery, research and clinical trials. Using advanced molecular analysis, generative AI can now create digital maps of chemical compounds, predicting interactions with unparalleled accuracy. 'Smart labs' are then able to analyze datasets, predict experimental outcomes and identify novel drug candidates. In clinical trials, generative AI integrates patient health records, genetic data and social factors to design more inclusive, real-world-representative studies. Real-time AI monitoring can flag adverse results early, mitigating risks and controlling costs. Lastly, generative AI is reshaping the provider landscape, delivering impact at every touchpoint. AI-powered diagnostics catch diseases earlier, and robotic surgical systems enhance accuracy. Wearable devices act as proactive health managers, continuously monitoring vital signs. Beyond clinical innovation, this technology can help simplify revenue cycles, automate processes and craft hyper-personalized wellness plans. This isn't just about efficiency or technology; it's a vision for a healthcare system that anticipates and meets patient needs while empowering providers to focus on delivering better outcomes. Yet, challenges like data and algorithmic bias demand countermeasures that include things like AI centers of excellence and fortified cybersecurity frameworks. The true power of GenAI lies in reshaping how payers build trust and deliver value. Data is the lifeblood of these applications of GenAI. However, transforming data into actionable intelligence remains a challenge that stifles innovation and progress. Too often, I see organizations set up foundational infrastructure only to lack bandwidth for the journey from insight to impact. The linear nature of this process delays value realization. Compounding this issue is what I see as an outdated reliance on business intelligence reports as the dominant channel for insight consumption. These static, often overloaded reports can slow decision cycles and constrain business users who must wait for analysts or automated processes to deliver the data they need. In a landscape where agility is everything, I think this method is no longer sustainable. On top of this, as healthcare shifts to cloud environments, costs can spiral. Therefore, organizations must balance scalability with financial discipline. AI-native infrastructures must support seamless transformations, real-time exploration and models that deliver new value. The goal is to refine, scale and deliver intelligence with precision. Organizations that align data with clear outcomes—ensuring readiness for GenAI—are the ones who will be best set up to unlock the transformative power of AI within their ecosystem. On top of the hurdles already outlined, ransomware attacks, data breaches and operational sabotage are rising, targeting interconnected healthcare systems. Healthcare data is unique, permanent and irreplaceable. Unlike financial records that can be reset, medical records are immutable, amplifying breach consequences. The digital sprawl, from wearable devices to AI diagnostics, expands the attack surface, making vigilance essential. As healthcare leaders address these challenges here are some of their approaches: 1. Modern cybersecurity is shifting to AI-powered frameworks for proactive defense. Extended detection and response (XDR) tools can analyze behavioral patterns, predicting and mitigating threats before escalation. 2. Ransomware attacks can paralyze operations, yet robust recovery strategies minimize impact. Resilience demands validated, immutable backups and swift recovery without data compromise. Align with business continuity planning (BCP) to ensure uninterrupted care delivery. 3. Streamlined digital identities minimize compliance gaps. Role-based access control (RBAC) and privileged access management (PAM) limit system access to authorized personnel, reducing risks. 4. As healthcare relies on application programming interfaces (APIs) for interoperability, safeguards must ensure minimal yet secure data sharing. Advanced data masking and encryption can further protect information during inter-system communication. 5. Predictive analytics, real-time threat detection and AI-driven incident response enable faster decision making and better risk management. Tailor your AI-driven managed detection and response (MDR) platforms for healthcare to enhance the protection of critical workflows and patient data. I believe healthcare is facing an existential reckoning that no app, algorithm or device alone can solve. Generative AI offers transformative potential, but only if paired with the infrastructure to turn data into decisions. Data strategies, in turn, are meaningless without robust cybersecurity to safeguard trust. Together, these trends reshape how care is delivered, operationalized and protected. Leaders must act decisively, invest wisely and design with purpose. The healthcare ecosystem will not transform through incrementalism—it demands bold vision and systemic alignment. Those who seize this moment will not only redefine their organizations but also set the standard for the future of healthcare. Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?
